Lee, Y.S., and J. Olefsky. 2021. Chronic tissue inflammation and metabolic disease. Genes & Development 355–6: 307–328.
Zhou, Z., B. Sun, D. Yu, et al. 2022. Gut Microbiota: An important player in type 2 diabetes mellitus. Frontiers in Cellular and Infection Microbiology 12: 834485.
Article CAS PubMed PubMed Central Google Scholar
Esser, N., S. Legrand-Poels, J. Piette, et al. 2014. Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes. Diabetes Research and Clinical Practice 1052: 141–150.
Khodabandehloo, H., S. Gorgani-Firuzjaee, G. Panahi, et al. 2016. Molecular and cellular mechanisms linking inflammation to insulin resistance and beta-cell dysfunction. Translational Research 1671: 228–256.
Thiem, K., S.T. Keating, M.G. Netea, et al. 2021. Hyperglycemic memory of innate immune cells promotes in vitro proinflammatory responses of human monocytes and murine macrophages. The Journal of Immunology 2064: 807–813.
Appari, M., K.M. Channon, and E. McNeill. 2018. Metabolic regulation of adipose tissue macrophage function in obesity and diabetes. Antioxidants & Redox Signaling 293: 297–312.
Boutens, L., and R. Stienstra. 2016. Adipose tissue macrophages: Going off track during obesity. Diabetologia 595: 879–894.
Drareni, K., J.F. Gautier, N. Venteclef, et al. 2019. Transcriptional control of macrophage polarisation in type 2 diabetes. Semin Immunopathol 414: 515–529.
Tesch, G.H. 2007. Role of macrophages in complications of type 2 diabetes. Clinical and Experimental Pharmacology and Physiology 3410: 1016–1019.
O’Grada, C.M., M.J. Morine, C. Morris, et al. 2014. PBMCs reflect the immune component of the WAT transcriptome–implications as biomarkers of metabolic health in the postprandial state. Molecular Nutrition & Food Research 584: 808–820.
Bouwens, M., L.A. Afman, and M. Muller. 2008. Activation of peroxisome proliferator-activated receptor alpha in human peripheral blood mononuclear cells reveals an individual gene expression profile response. BMC Genomics 9: 262.
Article PubMed PubMed Central Google Scholar
Gribov, A., M. Sill, S. Luck, et al. 2010. SEURAT: Visual analytics for the integrated analysis of microarray data. BMC Medical Genomics 3: 21.
Article PubMed PubMed Central Google Scholar
American Diabetes, A. 2019. Standards of medical care in diabetes-2019 abridged for primary care providers. Clin Diabetes 371: 11–34.
Li, K., Z. Liang, W. Xu, et al. 2022. CTRP7 Is a biomarker related to insulin resistance and oxidative stress: Cross-sectional and intervention studies in vivo and in vitro. Oxidative Medicine and Cellular Longevity 2022: 6877609.
PubMed PubMed Central Google Scholar
Hu, W., B. Zhan, Q. Li, et al. 2021. Circulating ctrp7 is a potential predictor for metabolic syndrome. Front Endocrinol (Lausanne) 12: 774309.
Yang, S., H. Dai, W. Hu, et al. 2021. Association between circulating follistatin-like-1 and metabolic syndrome in middle-aged and old population: A cross-sectional study. Diabetes/Metabolism Research and Reviews 372: e3373.
Albareda, M., J. Rodriguez-Espinosa, M. Murugo, et al. 2000. Assessment of insulin sensitivity and beta-cell function from measurements in the fasting state and during an oral glucose tolerance test. Diabetologia 4312: 1507–1511.
Rao, X., X. Huang, Z. Zhou, et al. 2013. An improvement of the 2^(-delta delta CT) method for quantitative real-time polymerase chain reaction data analysis. Biostatistics, bioinformatics and biomathematics 33: 71–85.
Zhao, A., D. Li, X. Mao, et al. 2022. GNG2 acts as a tumor suppressor in breast cancer through stimulating MRAS signaling. Cell Death & Disease 133: 260.
Hamada, M., Y. Tsunakawa, H. Jeon, et al. 2020. Role of MafB in macrophages. Experimental Animals 691: 1–10.
Guo, S., C. Dai, M. Guo, et al. 2013. Inactivation of specific beta cell transcription factors in type 2 diabetes. The Journal of Clinical Investigation 1238: 3305–3316.
Al Dubayee, M.S., H. Alayed, R. Almansour, et al. 2018. Differential expression of human peripheral mononuclear cells phenotype markers in type 2 diabetic patients and type 2 diabetic patients on metformin. Front Endocrinol (Lausanne) 9: 537.
Bleriot, C., E. Dalmas, F. Ginhoux, et al. 2023. Inflammatory and immune etiology of type 2 diabetes. Trends in Immunology 442: 101–109.
Donath, M.Y., and S.E. Shoelson. 2011. Type 2 diabetes as an inflammatory disease. Nature Reviews Immunology 112: 98–107.
Li, H., Y. Meng, S. He, et al. 2022. Macrophages, chronic inflammation, and insulin resistance. Cells 1119
Tran, M.T., M. Hamada, M. Nakamura, et al. 2016. MafB deficiency accelerates the development of obesity in mice. FEBS Open Bio 66: 540–547.
Artner, I., Y. Hang, M. Mazur, et al. 2010. MafA and MafB regulate genes critical to beta-cells in a unique temporal manner. Diabetes 5910: 2530–2539.
Auffray, C., D. Fogg, M. Garfa, et al. 2007. Monitoring of blood vessels and tissues by a population of monocytes with patrolling behavior. Science 3175838: 666–670.
Dick, S.A., J.A. Macklin, S. Nejat, et al. 2019. Self-renewing resident cardiac macrophages limit adverse remodeling following myocardial infarction. Nature Immunology 201: 29–39.
Franklin, R.A., W. Liao, A. Sarkar, et al. 2014. The cellular and molecular origin of tumor-associated macrophages. Science 3446186: 921–925.
Katoh, M.C., Y. Jung, C.M. Ugboma, et al. 2018. MafB is critical for glucagon production and secretion in mouse pancreatic alpha cells in vivo. Molecular and cellular biology 388
Tran, M.T.N., M. Hamada, H. Jeon, et al. 2017. MafB is a critical regulator of complement component C1q. Nature Communications 81: 1700.
Su, J.R., Z.H. Lu, Y. Su, et al. 2016. Relationship of serum adiponectin levels and metformin therapy in patients with type 2 diabetes. Hormone and Metabolic Research 482: 92–98.
Huang, T.F., Z.P. Tang, S. Wang, et al. 2019. Decrease in serum levels of adiponectin and increase in 8-OHdG: A culprit for cognitive impairment in the elderly patients with type 2 diabetes. Current Molecular Medicine 201: 44–50.
Engin, A. 2017. Adiponectin-resistance in obesity. Advances in Experimental Medicine and Biology 960: 415–441.
Article CAS PubMed Google Scholar
Ouchi, N., J.L. Parker, J.J. Lugus, et al. 2011. Adipokines in inflammation and metabolic disease. Nature Reviews Immunology 112: 85–97.
Sun, L., H. Deng, L. He, et al. 2015. The relationship between NR2E1 and subclinical inflammation in newly diagnosed type 2 diabetic patients. Journal of Diabetes and Its Complications 294: 589–594.
Ratheesh, M., J.P. Svenia, S. Asha, et al. 2017. Anti-inflammatory effect of a novel formulation of coconut inflorescence sap against ox-LDL induced inflammatory responses in human peripheral blood mononuclear cells by modulating TLR-NF-kappaB signaling pathway. Toxicology Mechanisms and Methods 278: 615–621.
Biro, M., M.A. Munoz, and W. Weninger. 2014. Targeting Rho-GTPases in immune cell migration and inflammation. British Journal of Pharmacology 17124: 5491–5506.
Zhou, H., and Y.J. Li. 2010. RhoA/Rho kinase: A novel therapeutic target in diabetic complications. Chinese Medical Journal (Engl) 12317: 2461–2466.
Theocharidis, G., B.E. Thomas, D. Sarkar, et al. 2022. Single cell transcriptomic landscape of diabetic foot ulcers. Nature Communications 131: 181.
Ozanska, A., D. Szymczak, and J. Rybka. 2020. Pattern of human monocyte subpopulations in health and disease. Scandinavian Journal of Immunology 921: e12883.
Zhang, Y., Q. Chen, and A.C. Ross. 2012. Retinoic acid and tumor necrosis factor-alpha induced monocytic cell gene expression is regulated in part by induction of transcription factor MafB. Experimental Cell Research 31818: 2407–2416.
留言 (0)